CytomX Therapeutics Inc Capital Reinvestment Ratio
CytomX Therapeutics Inc capital reinvestment ratio. CytomX Therapeutics Inc (CTMX) has a Capital Reinvestment Ratio of 0.01x as of March 2023, meaning it reinvests 0% of its operating cash flow ($9.35 Million) in capital expenditures ($48.00K). Check total reinvestment intensity of CytomX Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of CytomX Therapeutics Inc (2014–2020)
Capital reinvestment ratio of CytomX Therapeutics Inc from 2014 to 2020. This chart tracks CytomX Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore CytomX Therapeutics Inc (CTMX) equity growth momentum to track the company's year-over-year net asset growth rate.
CytomX Therapeutics Inc Capital Reinvestment Ratio by Year (2014–2020)
CytomX Therapeutics Inc capital reinvestment ratio by year from 2014 to 2020. For the full cash flow conversion analysis, see cash flow conversion of CytomX Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.44x | $5.26 Million | $2.31 Million | ▲ +4698.2% |
| 2017 | 0.01x | $170.37 Million | $1.56 Million | ▼ -82.5% |
| 2014 | 0.05x | $31.80 Million | $1.66 Million | — |